|
1
|
Virili C, Fallahi P, Antonelli A, Benvenga
S and Centanni M: Gut microbiota and Hashimoto's thyroiditis. Rev
Endocr Metab Disord. 19:293–300. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shanahan F: The gut microbiota in 2011:
Translating the microbiota to medicine. Nat Rev Gastroenterol
Hepatol. 9:72–74. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Walsh CJ, Guinane CM, OToole PW and Cotter
PD: Beneficial modulation of the gut microbiota. FEBS Letters.
588:4120–4130. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Power SE, OToole PW, Stanton C, Ross RP
and Fitzgerald GF: Intestinal microbiota, diet and health. Br J
Nutr. 111:387–402. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gao L, Wang JY, Ma SF and Li SJ: Research
progress on the relationship between intestinal flora and
thyroid-related diseases. J Shanxi Med Univ. 5:707–710. 2023.
|
|
6
|
Kamada N, Chen GY, Inohara N and Núñez G:
Control of pathogens and pathobionts by the gut microbiota. Nat
Immunol. 14:685–690. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sears CL and Garrett WS: Microbes,
microbiota, and colon cancer. Cell Host Microbe. 15:317–328. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schwabe RF and Jobin C: The microbiome and
cancer. Nat Rev Cancer. 13:800–812. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Louis P, Hold GL and Flint HJ: The gut
microbiota, bacterial metabolites and colorectal cancer. Nat Rev
Microbiol. 12:661–672. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Elinav E, Nowarski R, Thaiss CA, Hu B, Jin
C and Flavell RA: Inflammation-induced cancer: Crosstalk between
tumours, Immune cells and microorganisms. Nat Rev Cancer.
13:759–771. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Irrazábal T, Belcheva A, Girardin SE,
Martin A and Philpott DJ: The multifaceted role of the intestinal
microbiota in colon cancer. Mol Cell. 54:309–320. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
De Martel C, Ferlay J, Franceschi S,
Vignat J, Bray F, Forman D and Plummer M: Global burden of cancers
attributable to infections in 2008: A review and synthetic
analysis. Lancet Oncol. 13:607–615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu J, Luo M, Zhang Y, Cao G and Wang S:
Association of high-risk human papillomavirus infection duration
and cervical lesions with vaginal microbiota composition. Ann
Transl Med. 8:11612020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mitra A, MacIntyre DA, Ntritsos G, Smith
A, Tsilidis KK, Marchesi JR, Bennett PR, Moscicki AB and Kyrgiou M:
The vaginal microbiota associates with the regression of untreated
cervical intraepithelial neoplasia 2 lesions. Nat Commun.
11:19992020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tango CN, Seo SS, Kwon M, Lee DO, Chang HK
and Kim MK: Taxonomic and functional differences in cervical
microbiome associated with cervical cancer development. Sci Rep.
10:97202020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu S, Rhee KJ, Albesiano E, Rabizadeh S,
Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, et al: A
human colonic commensal promotes colon tumorigenesis via activation
of T helper type 17 T cell responses. Nat Med. 15:1016–1022. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Housseau F and Sears CL: Enterotoxigenic
Bacteroides fragilis (ETBF)-mediated colitis in Min (Apc+/-) mice:
A human commensal-based murine model of colon carcinogenesis. Cell
Cycle. 9:3–5. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Q, Sun W and Zhang H: Interaction of
gut microbiota with endocrine homeostasis and thyroid cancer.
Cancers. 14:26562022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li JZ, Ma DS and Ma ZJ: Research progress
on the correlation between intestinal flora and thyroid cancer.
Chin J General Surg. 6:482–484. 2021.
|
|
20
|
Xie Z, Zhou J, Zhang X and Li Z: Clinical
potential of microbiota in thyroid cancer therapy. Biochimica Et
Biochim Biophys Acta Mol Basis Dis. 1870:1669712024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cellini M, Santaguida MG, Virili C,
Capriello S, Brusca N, Gargano L and Centanni M: Hashimotos
thyroiditis and autoimmune gastritis. Front Endocrinol (Lausanne).
8:922017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Virili C and Centanni M: ‘With a little
help from my friends’-The role of microbiota in thyroid hormone
metabolism and enterohepatic recycling. Mol Cell Endocrinol.
458:39–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jašarević E, Morrison KE and Bale TL: Sex
differences in the gut microbiome-brain axis across the lifespan.
Philos Trans R Soc Lond B Biol Sci. 371:201501222016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Covelli D and Ludgate M: The thyroid, the
eyes and the gut: A possible connection. J Endocrinol Invest.
40:567–576. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ishaq HM, Mohammad IS, Guo H, Shahzad M,
Hou YJ, Ma C, Naseem Z, Wu X, Shi P and Xu J: Molecular estimation
of alteration in intestinal microbial composition in Hashimotos
thyroiditis patients. Biomed Pharmacother. 95:865–874. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao F, Feng J, Li J, Zhao L, Liu Y, Chen
H, Jin Y, Zhu B and Wei Y: Alterations of the gut microbiota in
hashimotos thyroiditis patients. Thyroid. 28:175–186. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Du L, Li R, Ge M, Wang Y, Li H, Chen W and
He J: Incidence and mortality of thyroid cancer in China,
2008–2012. Chin J Cancer Res. 31:144–151. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cabanillas ME, McFadden DG and Durante C:
Thyroid cancer. Lancet. 388:2783–2795. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kitahara CM and Sosa JA: The changing
incidence of thyroid cancer. Nat Rev Endocrinol. 12:646–653. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lortet-Tieulent J, Franceschi S, Dal Maso
L and Vaccarella S: Thyroid cancer ‘epidemic’ also occurs in low-
and middle-income countries. Int J Cancer. 144:2082–2087. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim J, Gosnell JE and Roman SA: Geographic
influences in the global rise of thyroid cancer. Nat Rev
Endocrinol. 16:17–29. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maruvada P, Leone V, Kaplan LM and Chang
EB: The human microbiome and obesity: Moving beyond associations.
Cell Host Microbe. 22:589–599. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stefura T, Zapała B, Gosiewski T,
Skomarovska O, Dudek A, Pędziwiatr M and Major P: Differences in
compositions of oral and fecal microbiota between patients with
obesity and controls. Medicina (Kaunas). 57:6782021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dong T, Zhao F, Yuan K, Zhu X, Wang N, Xia
F, Lu Y and Huang Z: Association between serum Thyroid-stimulating
hormone levels and salivary microbiome shifts. Front Cell Infect
Microbiol. 11:6032912021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nabhan F, Dedhia PH and Ringel MD: Thyroid
cancer, recent advances in diagnosis and therapy. Int J Cancer.
149:984–992. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee J, Yun MJ, Nam KH, Chung WY, Soh EY
and Park CS: Quality of life and effectiveness comparisons of
thyroxine withdrawal, triiodothyronine withdrawal, and recombinant
thyroid-stimulating hormone administration for low-dose radioiodine
remnant ablation of differentiated thyroid carcinoma. Thyroid.
20:173–179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schroeder PR, Haugen BR, Pacini F, Reiners
C, Schlumberger M, Sherman SI, Cooper DS, SchuffK G, Braverman LE,
Skarulis MC, et al: A comparison of short-term changes in
health-related quality of life in thyroid carcinoma patients
undergoing diagnostic evaluation with recombinant human thyrotropin
compared with thyroid hormone withdrawal. J Clin Endocrinol Metab.
91:878–884. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rubic M, Kuna SK, Tesic V, Samardzic T,
Despot M and Huic D: The most common factors influencing on quality
of life of thyroid cancer patients after thyroid hormone
withdrawal. Psychiatr Danub. 26:520–527. 2014.PubMed/NCBI
|
|
41
|
Sigal GA, Tavoni TM, Silva BMO, Kalil
Filho R, Brandão LG and Maranhão RC: Effects of Short-term
hypothyroidism on the lipid transfer to High-density lipoprotein
and other parameters related to lipoprotein metabolism in patients
submitted to thyroidectomy for thyroid cancer. Thyroid. 29:53–58.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Singh R, Tandon A, Gupta SK and Saroja K:
Optimal levothyroxine replacement adequately improves symptoms of
hypothyroidism; residual symptoms need further evaluation for other
than hypothyroidism causation. Indian J Endocrinol Metab.
21:830–835. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lin B, Zhao F, Liu Y, Wu X, Feng J, Jin X,
Yan W, Guo X, Shi S, Li Z, et al: Randomized clinical trial:
Probiotics alleviated Oral-Gut microbiota dysbiosis and thyroid
hormone Withdrawal-related complications in thyroid cancer patients
before radioiodine therapy following thyroidectomy. Front
Endocrinol (Lausanne). 13:8346742022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Feng J, Zhao F, Sun J, Lin B, Zhao L, Liu
Y, Jin Y, Li S, Li A and Wei Y: Alterations in the gut microbiota
and metabolite profiles of thyroid carcinoma patients. Int J
Cancer. 144:2728–2745. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Feng Q, Liang S, Jia H, Stadlmayr A, Tang
L, Lan Z, Zhang D, Xia H, Xu X, Jie Z, et al: Gut microbiome
development along the colorectal adenoma-carcinoma sequence. Nat
Commun. 6:65282015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fuhrman BJ, Feigelson HS, Flores R, Gail
MH, Xu X, Ravel J and Goedert JJ: Associations of the fecal
microbiome with urinary estrogens and estrogen metabolites in
postmenopausal women. J Clin Endocrinol Metab. 99:4632–4640. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jeffery IB, OToole PW, Öhman L, Claesson
MJ, Deane J, Quigley EM and Simrén M: An irritable bowel syndrome
subtype defined by species-specific alterations in faecal
microbiota. Gut. 61:997–1006. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang J, Zhang F, Zhao C, Xu Q, Liang C,
Yang Y, Wang H, Shang Y, Wang Y, Mu X, et al: Dysbiosis of the gut
microbiome is associated with thyroid cancer and thyroid nodules
and correlated with clinical index of thyroid function. Endocrine.
64:564–574. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yu X, Jiang W, Kosik RO, Song Y, Luo Q,
Qiao T, Tong J, Liu S, Deng C, Qin S, et al: Gut microbiota changes
and its potential relations with thyroid carcinoma. J Adv Res.
35:61–70. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lu G, Yu X, Jiang W, Luo Q, Tong J, Fan S,
Chai L, Gao D, Qiao T, Wang R, et al: Alterations of gut microbiome
and metabolite profiles associated with anabatic lipid
dysmetabolism in thyroid cancer. Front Endocrinol (Lausanne).
13:8931642022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ishaq HM, Mohammad IS, Hussain R, Parveen
R, Shirazi JH, Fan Y, Shahzad M, Hayat K, Li H, Ihsan A, et al:
Gut-Thyroid axis: How gut microbial dysbiosis associated with
euthyroid thyroid cancer. J Cancer. 13:2014–2028. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Quan Z, Zhang X, Wang S and Meng Y: Causal
analysis of the gut microbiota in differentiated thyroid carcinoma:
A two-sample Mendelian randomization study. Front Genetics.
14:12999302023. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sun X, Chen S, Zhao S, Wang J and Cheng H:
Causal relationship of genetically predicted gut microbiota with
thyroid cancer: A bidirectional two-sample mendelian randomization
study. Front Endocrinol (Lausanne). 15:12844722024. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hou T, Wang Q, Dai H, Hou Y, Zheng J, Wang
T, Lin H, Wang S, Li M, Zhao Z, et al: Interactive association
between gut microbiota and thyroid cancer. Endocrinology.
165:bqad1842023. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhu F, Zhang P, Liu Y, Bao C, Qian D, Ma
C, Li H and Yu T: Mendelian randomization suggests a causal
relationship between gut dysbiosis and thyroid cancer. Front Cell
Infect Microbiol. 13:12984432023. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhou J, Zhang X, Xie Z and Li Z: Exploring
reciprocal causation: Bidirectional mendelian randomization study
of gut microbiota composition and thyroid cancer. J Cancer Res Clin
Oncol. 150:752024. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hu S, Tang C, Wang L, Feng F, Li X, Sun M
and Yao L: Causal relationship between gut microbiota and
differentiated thyroid cancer: A two-sample Mendelian randomization
study. Front Oncol. 14:13755252024. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yan S, He J, Yu X, Shang J, Zhang Y, Bai
H, Zhu X, Xie X and Lee L: Causal relationship between gut
microbiota and thyroid nodules: A bidirectional two-sample
Mendelian randomization study. Front Endocrinol (Lausanne).
15:14170092024. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Knezevic J, Starchl C, Tmava Berisha A and
Amrein K: Thyroid-gut-axis: How does the microbiota influence
thyroid function? Nutrients. 12:17692020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Cao Y, Oh J, Xue M, Huh WJ, Wang J,
Gonzalez-Hernandez JA, Rice TA, Martin AL, Song D, Crawford JM, et
al: Commensal microbiota from patients with inflammatory bowel
disease produce genotoxic metabolites. Science. 378:eabm32332022.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Trapani KM, Boghossian LJ and Caskey E:
Clostridium subterminale septicemia in a patient with metastatic
gastrointestinal adenocarcinoma. Case Rep Infect Dis.
2018:60315102018.PubMed/NCBI
|
|
62
|
Dahmus JD, Kotler DL, Kastenberg DM and
Kistler CA: The gut microbiome and colorectal cancer: A review of
bacterial pathogenesis. J Gastrointest Oncol. 9:769–777. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kostic AD, Chun E, Robertson L, Glickman
JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold
GL, et al: Fusobacterium nucleatum potentiates intestinal
tumorigenesis and modulates the tumor-immune microenvironment. Cell
Host Microbe. 14:207–215. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Fan Y, Mao R and Yang J: NF-κB and STAT3
signaling pathways collaboratively link inflammation to cancer.
Protein Cell. 4:176–185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wang HP: Multiomics study on screening
biomarkers for papillary thyroid cancer (Doctors thesis). China
Medical University; Liaoning: 2024
|
|
66
|
Zhang L, Chen J, Xu C, Qi L and Ren Y:
Effects of iodine-131 radiotherapy on Th17/Tc17 and Treg/Th17 cells
of patients with differentiated thyroid carcinoma. Exp Ther Med.
15:2661–2666. 2018.PubMed/NCBI
|
|
67
|
Wang AY, Li CY, Xue G and Wang JF: The
relationship between intestinal flora and thyroid disease. J
Otorhinolaryngol Ophthalmol Shandong Univ. 1:132–139. 2023.
|
|
68
|
McBrearty N, Arzumanyan A, Bichenkov E,
Merali S, Merali C and Feitelson M: Short chain fatty acids delay
the development of hepatocellular carcinoma in HBx transgenic mice.
Neoplasia. 23:529–538. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhao H, Li H and Huang T: High urinary
iodine, thyroid autoantibodies, and Thyroid-stimulating hormone for
papillary thyroid cancer risk. Biol Trace Elem Res. 184:317–324.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Guerrero-Preston R, Godoy-Vitorino F,
Jedlicka A, Rodríguez-Hilario A, González H, Bondy J, Lawson F,
Folawiyo O, Michailidi C, Dziedzic A, et al: 16S rRNA amplicon
sequencing identifies microbiota associated with oral cancer, human
papilloma virus infection and surgical treatment. Oncotarget.
7:51320–51334. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhao J, Nian L, Kwok LY, Sun T and Zhao J:
Reduction in fecal microbiota diversity and short-chain fatty acid
producers in Methicillin-resistant Staphylococcus aureus infected
individuals as revealed by PacBio single molecule, real-time
sequencing technology. Eur J Clin Microbiol Infect Dis.
36:1463–1472. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Wang YY, Zhang JY, Jin XR and Wang NP:
Research progress on the relationship between intestinal flora and
thyroid diseases. Prog Modern Gen Surg China. 26:793–796. 2023.
|
|
73
|
Fröhlich E and Wahl R: Microbiota and
thyroid interaction in health and disease. Trends Endocrinol Metab.
30:479–490. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Frank DN, St Amand AL, Feldman RA,
Boedeker EC, Harpaz N and Pace NR: Molecular-phylogenetic
characterization of microbial community imbalances in human
inflammatory bowel diseases. Proc Natl Acad Sci USA.
104:13780–13785. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Lamberti C, Mangiapane E, Pessione A,
Mazzoli R, Giunta C and Pessione E: Proteomic characterization of a
selenium-metabolizing probiotic Lactobacillus reuteri Lb26 BM for
nutraceutical applications. Proteomics. 11:2212–2221. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Tam AA, Ozdemir D, Aydın C, Bestepe N,
Ulusoy S, Sungu N, Ersoy R and Cakir B: Association between
preoperative thyrotrophin and clinicopathological and aggressive
features of papillary thyroid cancer. Endocrine. 59:565–572. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Pushalkar S, Hundeyin M, Daley D,
Zambirinis CP, Kurz E, Mishra A, Mohan N, Aykut B, Usyk M, Torres
LE, et al: The pancreatic cancer microbiome promotes oncogenesis by
induction of innate and adaptive immune suppression. Cancer Discov.
8:403–416. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Virili C, Stramazzo I, Bagaglini MF,
Carretti AL, Capriello S, Romanelli F, Trimboli P and Centanni M:
The relationship between thyroid and human-associated microbiota: A
systematic review of reviews. Rev Endocr Metab Disord. 25:215–237.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kiss B, Mikó E, Sebő É, Toth J, Ujlaki G,
Szabó J, Uray K, Bai P and Árkosy P: Oncobiosis and microbial
metabolite signaling in pancreatic adenocarcinoma. Cancers (Basel).
12:10682020. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Pitt JM, Vétizou M, Gomperts Boneca I,
Lepage P, Chamaillard M and Zitvogel L: Enhancing the clinical
coverage and anticancer efficacy of immune checkpoint blockade
through manipulation of the gut microbiota. Oncoimmunology.
6:e11321372017. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wang SP, Rubio LA, Duncan SH, Donachie GE,
Holtrop G, Lo G, Farquharson FM, Wagner J, Parkhill J, Louis P, et
al: Pivotal roles for pH, Lactate, and Lactate-utilizing bacteria
in the stability of a human colonic microbial ecosystem. mSystems.
5:e00645–e00620. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Hu S, Liu L, Chang EB, Wang JY and Raufman
JP: Butyrate inhibits pro-proliferative miR-92a by diminishing
c-Myc-induced miR-17-92a cluster transcription in human colon
cancer cells. Mol Cancer. 14:1802015. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Li M, van Esch BCAM, Henricks PAJ, Garssen
J and Folkerts G: Time and concentration dependent effects of short
chain fatty acids on lipopolysaccharide- or tumor necrosis factor
α-Induced endothelial activation. Front Pharmacol. 9:2332018.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Zhang JT, Yi M, Li ZJ and Sun SX: Research
progress on the mechanism of butyrate in inflammatory response. J
Immunology. 12:1101–1104. 2015.
|
|
85
|
Zhou L, Zhang M, Wang Y, Dorfman RG, Liu
H, Yu T, Chen X, Tang D, Xu L, Yin Y, et al: Faecalibacterium
prausnitzii produces butyrate to maintain Th17/Treg balance and to
ameliorate colorectal colitis by inhibiting histone deacetylase 1.
Inflamm Bowel Dis. 24:1926–1940. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Rathod M, Kelkar M, Valvi S, Salve G and
De A: FOXA1 Regulation turns Benzamide HDACi treatment
effect-specific in BC, Promoting NIS gene-mediated targeted
radioiodine therapy. Mol Ther Oncolytics. 19:93–104. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Greenberg VL, Williams JM, Cogswell JP,
Mendenhall M and Zimmer SG: Histone deacetylase inhibitors promote
apoptosis and differential cell cycle arrest in anaplastic thyroid
cancer cells. Thyroid. 11:315–325. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Xiao X, Ning L and Chen H: Notch1 mediates
growth suppression of papillary and follicular thyroid cancer cells
by histone deacetylase inhibitors. Mol Cancer Ther. 8:350–356.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Duan H, Wang L, Huangfu M and Li H: The
impact of microbiota-derived short-chain fatty acids on macrophage
activities in disease: Mechanisms and therapeutic potentials.
Biomed Pharmacother. 165:1152762023. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Shen WT, Wong TS, Chung WY, Wong MG,
Kebebew E, Duh QY and Clark OH: Valproic acid inhibits growth,
induces apoptosis, and modulates apoptosis-regulatory and
differentiation gene expression in human thyroid cancer cells.
Surgery. 138:979–985. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Aponte-López A, Fuentes-Pananá EM,
Cortes-Muñoz D and Muñoz-Cruz S: Mast cell, the neglected member of
the tumor microenvironment: Role in breast cancer. J Immunol Res.
2018:25842432018. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Revilla G, Pons MP, Baila-Rueda L,
García-León A, Santos D, Cenarro A, Magalhaes M, Blanco RM, Moral
A, Ignacio Pérez J, et al: Cholesterol and 27-hydroxycholesterol
promote thyroid carcinoma aggressiveness. Sci Rep. 9:102602019.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Shang X, Zhong X and Tian X: Metabolomics
of papillary thyroid carcinoma tissues: Potential biomarkers for
diagnosis and promising targets for therapy. Tumour Biol.
37:11163–11175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Li JZ: Research on the correlation between
papillary thyroid carcinoma and intestinal flora (Masters thesis).
QingHai University; Xining: 2023
|
|
95
|
Mahfoudi R, Djeridane A, Benarous K,
Gaydou EM and Yousfi M: Structure-activity relationships and
molecular docking of thirteen synthesized flavonoids as horseradish
peroxidase inhibitors. Bioorg Chem. 74:201–211. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Danilovic DLS, Ferraz-de-Souza B, Fabri
AW, Santana NO, Kulcsar MA, Cernea CR, Marui S and Hoff AO:
25-Hydroxyvitamin D and TSH as risk factors or prognostic markers
in thyroid carcinoma. PLoS One. 11:e01645502016. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Huang NS, Chen XX, Wei WJ, Mo M, Chen JY,
Ma B, Yang SW, Xu WB, Wu J, Ji QH, et al: Association between
breast cancer and TC: A study based on 13 978 patients with breast
cancer. Cancer Med. 7:6393–6400. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Ervin SM, Li H, Lim L, Roberts LR, Liang
X, Mani S and Redinbo MR: Gut microbial β-glucuronidases reactivate
estrogens as components of the estrobolome that reactivate
estrogens. J Biol Chem. 294:18586–18599. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Pollet RM, DAgostino EH, Walton WG, Xu Y,
Little MS, Biernat KA, Pellock SJ, Patterson LM, Creekmore BC,
Isenberg HN, et al: An atlas of β-Glucuronidases in the human
intestinal microbiome. Structure. 25:967–977.e5. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Rubio GA, Catanuto P, Glassberg MK, Lew JI
and Elliot SJ: Estrogen receptor subtype expression and regulation
is altered in papillary thyroid cancer after menopause. Surgery.
163:143–149. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Qiu YB, Liao LY, Jiang R, Xu M, Xu LW,
Chen GG and Liu ZM: PES1 promotes the occurrence and development of
papillary thyroid cancer by upregulating the ERα/ERβ protein ratio.
Sci Rep. 9:10322019. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Wang Z, He L, Sun W, Qin Y, Dong W, Zhang
T, Zhang P and Zhang H: miRNA-299-5p regulates estrogen receptor
alpha and inhibits migration and invasion of papillary thyroid
cancer cell. Cancer Manag Res. 10:6181–6193. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Vannucchi G, De Leo S, Perrino M, Rossi S,
Tosi D, Cirello V, Colombo C, Bulfamante G, Vicentini L and
Fugazzola L: Impact of estrogen and progesterone receptor
expression on the clinical and molecular features of papillary
thyroid cancer. Eur J Endocrinol. 173:29–36. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
He Q, Sun H, Li F and Liang N: Obesity and
risk of differentiated thyroid cancer: A large-scale case-control
study. Clin Endocrinol (Oxf). 91:869–878. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Riva A, Borgo F, Lassandro C, Verduci E,
Morace G, Borghi E and Berry D: Pediatric obesity is associated
with an altered gut microbiota and discordant shifts in Firmicutes
populations. Environ Microbiol. 19:95–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Watanabe H, Katsura T, Takahara M,
Miyashita K, Katakami N, Matsuoka TA, Kawamori D and Shimomura I:
Plasma lipopolysaccharide binding protein level statistically
mediates between body mass index and chronic microinflammation in
Japanese patients with type 1 diabetes. Diabetol Int. 11:293–297.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
De Melo TG, Souza AL, Ficher E, Fernandes
AM, Montali Da Assumpção LV, Monte Alegre S and Zantut-Wittmann DE:
Reduced insulin sensitivity in differentiated thyroid cancer
patients with suppressed TSH. Endo Res. 43:73–79. 2018. View Article : Google Scholar
|
|
108
|
Heidari Z, Abdani M and Mansournia MA:
Insulin resistance associated with differentiated thyroid
carcinoma: Penalized conditional logistic regression analysis of a
matched case-control study data. Int J Endocrinol Metab.
16:e145452018.PubMed/NCBI
|
|
109
|
Knuppel A, Fensom GK, Watts EL, Gunter MJ,
Murphy N, Papier K, Perez-Cornago A, Schmidt JA, Smith Byrne K,
Travis RC and Key TJ: Circulating Insulin-like Growth Factor-I
concentrations and risk of 30 cancers: Prospective analyses in UK
Biobank. Cancer Res. 80:4014–4021. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Vella V and Malaguarnera R: The emerging
role of insulin receptor isoforms in TC: Clinical implications and
new perspectives. Int J Mol Sci. 19:38142018. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Manzella L, Massimino M, Stella S, Tirrò
E, Pennisi MS, Martorana F, Motta G, Vitale SR, Puma A, Romano C,
et al: Activation of the IGF axis in thyroid cancer: Implications
for tumorigenesis and treatment. Int J Mol Sci. 20:32582019.
View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Li YH, Gao XF, Guo TT, Zhang J, Zhang CZ
and Li J: Research progress on the mechanism of obesity combined
with thyroid cancer. Chin J Gen Surg. 4:311–315. 2023.
|
|
113
|
Song YC, Yu XQ and Li D: Structural
changes of gut microbiota in papillary thyroid carcinoma patients
with postoperative hypothyroidism. J Tongji Univ. 2:144–151.
2019.
|
|
114
|
Tang YJ: Relationships of Preoperative Gut
Microbiota and Postoperative Nausea and Vomiting in Female Patients
Undergoing Thyroid Cancer Surgery: A Prospective Observational
Study (Masters thesis). Fujian Medicine University; Fuzhou, China:
2023
|
|
115
|
Spaggiari G, Brigante G, De Vincentis S,
Cattini U, Roli L, De Santis MC, Baraldi E, Tagliavini S, Varani M,
Trenti T, et al: Probiotics ingestion does not directly affect
thyroid hormonal parameters in hypothyroid patients on
levothyroxine treatment. Front Endocrinol (Lausanne). 8:3162017.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Ludgate ME, Masetti G and Soares P: The
relationship between the gut microbiota and thyroid disorders. Nat
Rev Endocrinol. 20:511–525. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Chen D, Wu J, Jin D, Wang B and Cao H:
Fecal microbiota transplantation in cancer management: Current
status and perspectives. Int J Cancer. 145:2021–2031. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Routy B, Le Chatelier E, Derosa L, Duong
CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C,
Roberti MP, et al: Gut microbiome influences efficacy of PD-1-based
immunotherapy against epithelial tumors. Science. 359:91–97. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Zheng L, Zhang L, Tang L, Huang D, Pan D,
Guo W, He S, Huang Y, Chen Y, Xiao X, et al: Gut microbiota is
associated with response to 131I therapy in patients
with papillary thyroid carcinoma. Eur J Nucl Med Mol Imaging.
50:1453–1465. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Moshkelgosha S, Verhasselt HL, Masetti G,
Covelli D, Biscarini F, Horstmann M, Daser A, Westendorf AM,
Jesenek C, Philipp S, et al: Modulating gut microbiota in a mouse
model of Graves orbitopathy and its impact on induced disease.
Microbiome. 9:452021. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Su X, Yin X, Liu Y, Yan X, Zhang S, Wang
X, Lin Z, Zhou X, Gao J, Wang Z and Zhang Q: Gut dysbiosis
contributes to the imbalance of Treg and Th17 cells in graves
disease patients by propionic acid. J Clin Endocrinol Metab.
105:dgaa5112020. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Su X, Zhao Y, Li Y, Ma S and Wang Z: Gut
dysbiosis is associated with primary hypothyroidism with
interaction on gut-thyroid axis. Clin Sci (Lond). 134:1521–1535.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Docimo G, Cangiano A, Romano RM,
Pignatelli MF, Offi C, Paglionico VA, Galdiero M, Donnarumma G,
Nigro V, Esposito D, et al: The Human Microbiota in endocrinology:
Implications for pathophysiology, treatment, and prognosis in
thyroid diseases. Front Endocrinol (Lausanne). 11:5865292020.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Lin JD, Chao TC, Huang MJ, Weng HF and
Tzen KY: Use of RAI for thyroid remnant ablation in
well-differentiated thyroid carcinoma to replace thyroid
reoperation. Am J Clin Oncol. 21:77–81. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Lu G, Gao D, Liu Y, Yu X, Jiang W and Lv
Z: Early and long-term responses of intestinal microbiota and
metabolites to 131I treatment in differentiated thyroid cancer
patients. BMC Medicine. 22:3002024. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Luster M, Clarke SE, Dietlein M, Lassmann
M, Lind P, Oyen WJG, Tennvall J and Bombardieri E; European
Association of Nuclear Medicine (EANM), : Guidelines for
radioiodine therapy of differentiated thyroid cancer. Eur J Nucl
Med Mol Imaging. 35:1941–1959. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Panebianco C, Andriulli A and Pazienza V:
Pharmacomicrobiomics: Exploiting the drug-microbiota interactions
in anticancer therapies. Microbiome. 6:922018. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Lin B, Zhao F, Liu Y, Sun J, Feng J, Zhao
L, Wang H, Chen H, Yan W, Guo X, et al: Alterations in oral
microbiota of differentiated thyroid carcinoma patients with
xerostomia after radioiodine therapy. Front Endocrinol (Lausanne).
13:8959702022. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Feller L, Altini M and Lemmer J:
Inflammation in the context of oral cancer. Oral Oncol. 49:887–892.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Atarashi K, Suda W, Luo C, Kawaguchi T,
Motoo I, Narushima S, Kiguchi Y, Yasuma K, Watanabe E, Tanoue T, et
al: Ectopic colonization of oral bacteria in the intestine drives
TH1 cell induction and inflammation. Science. 358:359–365. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Larsen JM: The immune response to
Prevotella bacteria in chronic inflammatory disease. Immunology.
151:363–374. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Mahowald MA, Rey FE, Seedorf H, Turnbaugh
PJ, Fulton RS, Wollam A, Shah N, Wang C, Magrini V, Wilson RK, et
al: Characterizing a model human gut microbiota composed of members
of its two dominant bacterial phyla. Proc Natl Acad Sci USA.
106:5859–5864. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Lu G, Gao D, Jiang W, Yu X, Tong J, Liu X,
Qiao T, Wang R, Zhang M, Wang S, et al: Disrupted gut microecology
after high-dose 131I therapy and radioprotective effects
of arachidonic acid supplementation. Eur J Nucl Med Mol Imaging.
51:2395–2408. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Samimi H and Haghpanah V: Gut microbiome
and radioiodine-refractory papillary thyroid carcinoma
pathophysiology. Trends Endocrinol Metab. 31:627–630. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Coerts HI, de Keizer B, Marlowe RJ and
Verburg FA: Recombinant or endogenous TSH for RAI therapy in
thyroid cancer: State of knowledge and current controversies. Eur J
Endocrinol. 188:lvad0062023. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Horvath E, Skoknic V, Majlis S, Tala H,
Silva C, Castillo E, Whittle C, Niedmann JP and González P:
Radioiodine-induced salivary gland damage detected by
ultrasonography in patients treated for papillary TC: Radioactive
iodine activity and risk. Thyroid. 30:1646–1655. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Sunavala-Dossabhoy G and Petti S: Effect
of recombinant human thyroid stimulating hormone on long-term
salivary gland dysfunction in thyroid cancer patients treated with
RAI. A systematic review. Oral Oncol. 136:1062802023. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Sivan A, Corrales L, Hubert N, Williams
JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B,
Alegre ML, et al: Commensal Bifidobacterium promotes antitumor
immunity and facilitates anti-PD-L1 efficacy. Science.
350:1084–1089. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Shi X, Yu PC, Lei BW, Li CW, Zhang Y, Tan
LC, Shi RL, Wang J, Ma B, Xu WB, et al: Association between
programmed death-ligand 1 expression and clinicopathological
characteristics, structural recurrence, and biochemical
recurrence/persistent disease in medullary thyroid carcinoma.
Thyroid. 29:1269–1278. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Capdevila J, Wirth LJ, Ernst T, Ponce Aix
S, Lin CC, Ramlau R, Butler MO, Delord JP, Gelderblom H, Ascierto
PA, et al: PD-1 blockade in anaplastic thyroid carcinoma. J Clin
Oncol. 38:2620–2627. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Xu JW and Gu J: Research progress on the
relationship between intestinal flora and thyroid cancer. J Clin
Oncol. 2:176–180. 2021.
|
|
142
|
Schlumberger M and Leboulleux S: Current
practice in patients with differentiated TC. Nat Rev Endocrinol.
17:176–188. 2021. View Article : Google Scholar : PubMed/NCBI
|
